go back

Kansas rates for HCPCS Q2053

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $549,541 · 10th–90th $436,516–$2,137,9620%20%10th90th$549,541Professionalmedian $489,779 · 10th–90th $467,735–$562,3410%50%10th90th$489,779$100.0K$200.0K$500.0K$1.0M$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$549,540.87 / $575,439.94 / $2,137,962.09
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $575,439.94
BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$436,515.83 / $436,515.83 / $467,735.14
BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$467,735.14 / $467,735.14 / $467,735.14
Cigna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $588,843.66
Medica
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$457,088.19 / $575,439.94 / $1,288,249.55
Medica
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$1,000,000.00 / $1,000,000.00 / $1,000,000.00
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $512,861.38
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$467,735.14 / $489,778.82 / $549,540.87